CT-2401

N/A

Report date: 2025/08/15 11:52:35

Base Information

Drug NameCT-2401
Drug Alias NameCT-2401
ClassificationCell and gene therapy > Gene therapy > mRNACell and gene therapy > Gene therapy > LNP
Mechanisms of ActionT-cell immunoglobulin and mucin domain-containing protein 4 gene transference
TargetsT-cell immunoglobulin and mucin domain-containing protein 4
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarisma Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarisma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A